Intellia Therapeutics
IPORevolutionize the course of medicine
Public · Cambridge, United States · Founded 2014 · $85.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- intelliatx.com
- Total Funding
- $85.0M
- Last Round
- $70.0M Series BSep 2015
- Rounds
- 2
- Type
- Public
About
Leading clinical-stage genome editing company developing novel, potentially curative therapeutics using CRISPR-based technology.
Summary
Intellia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $85.0M in total across 2 rounds, most recently a $70.0M Series B round in Sep 2015. Investors include OrbiMed, Atlas Venture and Janus Fund.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2016
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...